SEC Will Probe Illumina With Investigation Into Grail Acquisition

Illumina received notice in July that the Securities and Exchange Commission (SEC) was conducting an investigation into the company’s acquisition of Grail, requesting documents from the company over the beleaguered acquisition.
Source: Drug Industry Daily